Suzhou Highfine Biotech Co., Ltd. (SHE:301393)

Market Cap	6.30B
Revenue (ttm)	495.86M
Net Income (ttm)	139.02M
Shares Out	106.97M
EPS (ttm)	1.28
PE Ratio	46.00
Forward PE	39.23
Dividend	0.39 (0.66%)
Ex-Dividend Date	May 22, 2025

Volume	2,182,589
Average Volume	3,614,521
Open	59.55
Previous Close	58.85
Day's Range	59.10 - 60.50
52-Week Range	33.26 - 63.80
Beta	1.14
RSI	58.16
Earnings Date	Aug 29, 2025

About Suzhou Highfine Biotech

Suzhou Highfine Biotech Co., Ltd. manufactures and sells chemicals for pharmaceutical research and development, and API production companies in China. The company’s products include characteristic amide bonds, building blocks, protein reagents, protein crosslinkers, peptide reagents, protective amino acids, ionic liquids, PROTAC reagents, unnatural amino acids, pharmaceutical reagents of liposomes and lipid nanoparticles, nucleotide reagents, etc. Its products are used in fields of peptide, nucleotide, and pharmaceutical synthesis. The company ...

• Industry: Pharmaceutical Preparations
• Founded: 2003
• Employees: 428
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301393

Financial Performance

In 2024, Suzhou Highfine Biotech's revenue was 451.87 million, an increase of 16.22% compared to the previous year's 388.79 million. Earnings were 134.05 million, an increase of 35.44%.